Details

Autor(en) / Beteiligte

• Poveda-Andrés, José Luis
• Ruiz-Caldes, María José
• Carrera-Soler, María José
• Clopés-Estela, Ana
• Flores-Moreno, Sandra
• García-Pellicer, Javier
• Giráldez-Quiroga, Míriam
• López-Briz, Eduardo
• Lozano-Blázquez, Ana
• Megías-Vericat, Juan Eduardo
• Tordera-Baviera, María
• Valero-García, Silvia

Titel

Pharmacotherapeutic management of advanced therapy drugs

Ist Teil von

• Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2022-01, Vol.46 (2), p.88

Ort / Verlag

Spain

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• Advanced therapy drugs have emerged in recent years as new pharmacotherapeutic strategies. In this context, hospital pharmacy services have had to adapt to the new challenges posed by the  inclusion of advanced therapies in their roster of services against the  background of the complex pharmacotherapeutic process patients typically go through.All the activities carried out in the hospital pharmacy services must abide by  the rules established in the Spanish legislation and ensure both the quality of  the different drugs they manage and the safety of every single patient.Advanced therapy drugs are associated certain peculiarities, including the need  to select and evaluate potential candidates to receive them; recourse to  financing mechanisms based on risk sharing; and their extreme fragility, which  means that the personnel in charge of handling them must be properly trained  to maintain their viability and that special storage conditions, involving  temperatures below 180 ºC in the case of chimeric antigen receptor T cell  therapies, must be maintained. In addition, use of advanced therapy  medications in the clinical setting has made it necessary for scientific societies  to produce consensus documents recognizing the pivotal role of hospital  pharmacists as indispensable members of the multidisciplinary healthcare team  and ensuring the same traceability, conservation, custody and  pharmacotherapeutical monitoring standards imposed on other drugs to  provide for adequate pharmaceutical care. Scientific societies have also  highlighted the importance of intensifying clinical research, an essential  requirement for the safe incorporation of new therapeutic targets. The present  document is intended to describe the challenges pharmacists may face when  using advanced therapy drugs at the different stages or processes in the  patient's clinical journey.